We are live on ! Find out more
VERV

Verve Therapeutics
VERV

Delisted

VERV was delisted on the 24th of July, 2025.

Back to rankings

6 hedge funds and large institutions have $1.24M invested in Verve Therapeutics in 2025 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 169 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

81.59% less ownership

Funds ownership: 81.84% → 0.26% (-82%)

97% less funds holding

Funds holding: 175 → 6 (-169)

100% less capital invested

Capital invested by funds: $819M → $1.24M (-$818M)

100% less funds holding in top 10

Funds holding in top 10: 3 → 0 (-3)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 169

Holders
6
Holders Change
-169
Holders Change %
-96.57%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
2
Reduced
1
Closed
169
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
XT
XTX Topco
Cayman Islands
+$955K
2
IA
IFP Advisors
Florida
+$4.29K

Top Sellers

Rank Fund Capital Flow
1
AI
Alphabet Inc
California
-$137M
2
BlackRock
BlackRock
New York
-$82.6M
3
PCM
Pentwater Capital Management
Florida
-$75.5M
4
Vanguard Group
Vanguard Group
Pennsylvania
-$47.1M
5
CC
Casdin Capital
New York
-$46M
Name Holding Trade Value Shares
Change 		Change in
Stake
GCM
1
Greenland Capital Management
New York
$556K – – –
DekaBank Deutsche Girozentrale
2
DekaBank Deutsche Girozentrale
Germany
$341K – – –
BIG
3
Brooklyn Investment Group
New York
$197K – – –
IA
4
IFP Advisors
Florida
$112K +$4.29K +387 +4%
Osaic Holdings
5
Osaic Holdings
Arizona
$37.6K -$1.36K -123 -4%
AI
6
Alphabet Inc
California
– -$137M -12,168,489 Closed
BlackRock
7
BlackRock
New York
– -$82.6M -7,356,721 Closed
PCM
8
Pentwater Capital Management
Florida
– -$75.5M -6,720,000 Closed
Vanguard Group
9
Vanguard Group
Pennsylvania
– -$47.1M -4,191,854 Closed
CC
10
Casdin Capital
New York
– -$46M -4,095,571 Closed
FCM
11
Farallon Capital Management
California
– -$40.6M -3,612,000 Closed
AAM
12
Alpine Associates Management
Florida
– -$30.8M -2,738,212 Closed
State Street
13
State Street
Massachusetts
– -$29.5M -2,626,859 Closed
AVM
14
Arch Venture Management
Illinois
– -$22.6M -2,008,809 Closed
UBS Group
15
UBS Group
Switzerland
– -$21M -1,870,522 Closed
Hudson Bay Capital Management
16
Hudson Bay Capital Management
Connecticut
– -$19.6M -1,747,598 Closed
Geode Capital Management
17
Geode Capital Management
Massachusetts
– -$19.1M -1,704,394 Closed
BBA
18
Baker Bros. Advisors
New York
– -$19M -1,691,530 Closed
N
19
Nuveen
North Carolina
– -$18.1M -1,611,913 Closed
Goldman Sachs
20
Goldman Sachs
New York
– -$16.7M -1,482,642 Closed
JP Morgan Chase
21
JP Morgan Chase
New York
– -$12.8M -1,141,911 Closed
Renaissance Technologies
22
Renaissance Technologies
New York
– -$11.8M -1,047,600 Closed
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
– -$9.18M -817,532 Closed
Two Sigma Investments
24
Two Sigma Investments
New York
– -$9.12M -812,360 Closed
RG
25
Redmile Group
California
– -$8.31M -740,261 Closed
1
2 3 4 5

VERV Hedge Fund Activity: Q3 2025 in Review

6 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Verve Therapeutics (VERV) for Q3 2025, worth a combined $1.24M — down 100% from $819M a quarter earlier.

Sellers outnumbered buyers: 169 funds closed out of VERV and 0 opened new positions — a net loss of 169 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was XTX Topco, adding an estimated $955K. The largest seller was Alphabet Inc, exiting entirely with an estimated $137M sold.

  • 6 institutional investors held Verve Therapeutics (VERV) as of Q3 2025, down from 175 in Q2 2025.
  • Funds reported $1.24M of Verve Therapeutics stock for Q3 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Verve Therapeutics positions in Q3 2025 and 169 closed out, a net change of -169 holders.
  • The largest Verve Therapeutics buyer in Q3 2025 was XTX Topco, an estimated $955K added.
  • The largest Verve Therapeutics seller in Q3 2025 was Alphabet Inc, an estimated $137M sold.

Based on aggregated 13F filings for Q3 2025.